Muhammad, Khalid <br/><br/>
Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells.  [electronic resource] 

 -  Annals of the rheumatic diseases  Aug 2011 
 - 1507-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2010.141325  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antirheumatic Agents--pharmacology<br/>Arthritis, Rheumatoid--drug therapy<br/>B-Lymphocyte Subsets--drug effects<br/>Etanercept<br/>Female<br/>Gene Rearrangement, B-Lymphocyte--genetics<br/>Humans<br/>Immunoglobulin G--pharmacology<br/>Immunoglobulin Variable Region--genetics<br/>Immunologic Memory--genetics<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Receptors, Interleukin-6--antagonists & inhibitors<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Somatic Hypermutation, Immunoglobulin--immunology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors